Literature DB >> 27861411

"Tag Team" Glioblastoma Therapy: Results From a Phase 1 Trial of Toca 511 and 5-Fluorocytosine for Recurrent High-Grade Glioma.

Joslyn K Strebe1, Jonathan A Lubin, John S Kuo.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2016        PMID： 27861411     DOI： 10.1227/01.neu.0000508605.38694.fd

Source DB:  PubMed          Journal:  Neurosurgery        ISSN： 0148-396X            Impact factor:   4.654


× No keyword cloud information.
  2 in total

Review 1.  Glioblastoma Treatments: An Account of Recent Industrial Developments.

Authors:  Edouard Alphandéry
Journal:  Front Pharmacol       Date:  2018-09-13       Impact factor: 5.810

2.  Comprehensively investigating the expression levels and the prognostic role of transforming growth factor beta-induced (TGFBI) in glioblastoma multiforme.

Authors:  Jun Yin; Jin-Song Liu; Mei Feng; Jiao-Ming Li; Shun Lu; Mu Yang; Bang-Rong Cao; Jin-Yi Lang; Xiao-Dong Zhu
Journal:  Transl Cancer Res       Date:  2020-10       Impact factor: 1.241
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.